Shenzhen Weiguang Biological Products Co (SZSE:002880) Interest Expense : ¥-18 Mil (TTM As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Shenzhen Weiguang Biological Products Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Shenzhen Weiguang Biological Products Co's interest expense for the three months ended in Mar. 2024 was ¥ -5 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-18 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Shenzhen Weiguang Biological Products Co's Operating Income for the three months ended in Mar. 2024 was ¥ 60 Mil. Shenzhen Weiguang Biological Products Co's Interest Expense for the three months ended in Mar. 2024 was ¥ -5 Mil. Shenzhen Weiguang Biological Products Co's Interest Coverage for the quarter that ended in Mar. 2024 was 13.16. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Shenzhen Weiguang Biological Products Co Interest Expense Historical Data

The historical data trend for Shenzhen Weiguang Biological Products Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Weiguang Biological Products Co Interest Expense Chart

Shenzhen Weiguang Biological Products Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-0.40

-1.06

-2.77

-2.06

-14.34

Shenzhen Weiguang Biological Products Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-1.01	-1.36	-7.30	-4.68	-4.58

Shenzhen Weiguang Biological Products Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-18 Mil.

Shenzhen Weiguang Biological Products Co (SZSE:002880) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Shenzhen Weiguang Biological Products Co's Interest Expense for the three months ended in Mar. 2024 was ¥-5 Mil. Its Operating Income for the three months ended in Mar. 2024 was ¥60 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was ¥546 Mil.

Shenzhen Weiguang Biological Products Co's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2024 )	/	Interest Expense (Q: Mar. 2024 )
	=	-1	*	60.323	/	-4.584
	=	13.16

The higher the ratio, the stronger the company's financial strength is.

Shenzhen Weiguang Biological Products Co (SZSE:002880) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Weiguang Biological Products Co Ltd (SZSE:002880) » Definitions » Interest Expense

Traded in Other Exchanges

N/A

Address

Guangming Street, No. 3402, Guangqiao Avenue, Guangming New District, Guangdong Province, Guangming, CHN, 518107

Website

http://www.szwg.com

Shenzhen Weiguang Biological Products Co Ltd is the pharmaceutical company. It is mainly engaged in the research and development, production and sales of blood products. The company's products portfolio includes human albumin, intravenous immunoglobulin (pH4), lyophilized human immunoglobulin (pH4), human immunoglobulin, hepatitis B human immunoglobulin, rabies immunoglobulin, tetanus Human immunoglobulin, histamine human immunoglobulin, human fibrinogen, a total of 21 varieties of 21 specifications.

Shenzhen Weiguang Biological Products Co (SZSE:002880) Headlines

No Headlines